Table 1.
Studies of mitochondrial transplantation in human sample for each mitochondria delivery method
| Donor cell/tissue | Recipient cell/tissue | Delivery method | Reference |
|---|---|---|---|
| Human MSCs | MDA-MB-231 (human breast cancer cell line) | Co-incubation | (41) |
| Rectus abdominis muscle (in pediatric patients with refractory cardiogenic shock after ischemia-reperfusion injury [IRI]) | Myocardium (in pediatric patients with refractory cardiogenic shock after ischemia-reperfusion injury [IRI]) | Direct injection (autologus transplantation) | (42) |
| Human UC-MSCs | Human UC-MSCs | Centrifugation | (43) |
| MRC-5 (human fetal lung fibroblast cell line) | MRC-5 | Magnetomitotransfer | (44) |
| 143B cells (human osteosarcoma cell line) | MERRF B2 cybrid cells (fused 143B ρ° cells with enucleated skin fibroblasts from MERRF syndrome patient) | Cell-penetrating peptide | (45) |
| HeLa cells | MDA-MB-231 | Biocompatible polymer | (46) |
| MDA-MB-453 (human breast cancer cell line) | 143BTK ρ° cells (human osteosarcoma cell line) | Photothermal nanoblade | (47) |
| HeLa cells | HeLa cells | Fluidic force microscope (FluidFM) | (48) |